ArticleTheranostics2024
Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis.
Abstract read
In one paragraph
Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed.
- Exercise-induced protein lactylation: From molecular mechanisms to precision health applications.iScience · 2026Review
- Post‑translational modifications in atherosclerosis: Roles, mechanisms and therapeutic potential (Review).International journal of molecular medicine · 2026Review
- Unveiling the "Glycolysis-Lactate-Lactylation" Axis: A Novel Target in Ischemic Cerebrovascular Disease.Neuroscience bulletin · 2026Review
- The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.Oncogene · 2026Review
- Monocyte Dll4 Contributes to Systemic Inflammation in People Living With HIV.Circulation research · 2026Article
- Crosstalk between lactylation and other post-translational modifications in health and diseases.Molecular biomedicine · 2026Review
- Protein lactylation in health and diseases: molecular mechanisms, biological significance, and clinical implications.Signal transduction and targeted therapy · 2026Review
- Lactate as a Cardiovascular Exerkine: Mechanisms, Signaling Pathways, and Clinical Implications.Biomolecules · 2026Review
- The Trojan Horse system composed of platelet membrane and extracellular vesicles inhibits atherosclerotic plaque progression.iScience · 2026Article
- Metabolic Reprogramming-Driven Cardiovascular Immune Damage: From Glyco-Lipotoxicity and Epigenetic Memory to Multidimensional Cross-Organ Communication Networks.International journal of molecular sciences · 2026Review
- Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets.Journal of the American Heart Association · 2026Review
- Lactylation and lactate: insights into muscle cell epigenetic regulators in exercise.Molecular medicine (Cambridge, Mass.) · 2026Review
- Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances.Signal transduction and targeted therapy · 2026Review
- Triggering receptor expressed on myeloid cell family in atherosclerosis: from mechanisms to intervention strategies.Cell communication and signaling : CCS · 2026Review
- Lactate metabolism and lactylation: Therapeutic and pre-clinical implications in neovascularization in peripheral artery disease.Journal of pharmaceutical analysis · 2026Review
- Lactylation and acetylation: parallel paths, divergent deeds, and research dilemmas.Journal of translational medicine · 2026Review
- Focus on Lactate and Lactylation Modification: The Potential Role in Ophthalmic Disease Treatment.International journal of molecular sciences · 2026Review
- Flipping the Switch: MeCP2-Mediated Lactylation Rewires Microglial Metabolism and Inflammation via the HK2/mTOR Axis in Poststroke Neuroinflammation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Lactylation and macrophage polarization from a clinical perspective: pathological mechanisms and therapeutic potential.Frontiers in immunology · 2026Review
- Lactylation: a metabolic-epigenetic driver in atherosclerosis pathogenesis and therapeutic targeting.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Liangqi ChenDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Meiju ZhangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xueyan YangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yanan WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Tuo HuangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xin LiDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yunting BanDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Qifeng LiDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Qingyuan YangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yongxiang ZhangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yang ZhengDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Di WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaoqi WangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiujie ShiThe Clinical Skills Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Maomao ZhangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yong SunDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jian WuDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Apolipoproteins EAtherosclerosisMacrophagesMethyl-CpG-Binding Protein 2AnimalsCore Binding Factor Alpha 2 SubunitDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLPhysical Conditioning, AnimalPlaque, AtheroscleroticProtein Processing, Post-TranslationalApolipoproteins ECore Binding Factor Alpha 2 SubunitMECP2 protein, humanMecp2 protein, mouseMethyl-CpG-Binding Protein 2atherosclerosischromatin accessibilityexerciseH3K36me3macrophages polarizationMeCP2 lactylation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.